STOCK TITAN

22Nd Century Stock Price, News & Analysis

XXII Nasdaq

Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.

22nd Century Group (NASDAQ: XXII) pioneers plant-based solutions for tobacco harm reduction through advanced biotechnology. This news hub provides investors and stakeholders with essential updates on regulatory milestones, product innovations, and operational developments central to the company's mission of reducing nicotine addiction.

Access authoritative coverage of FDA communications, VLN product advancements, and manufacturing capacity updates. Our curated collection includes earnings reports, patent filings, and scientific research collaborations that demonstrate 22nd Century's leadership in developing reduced-nicotine tobacco products.

Key updates feature the company's Modified Risk Tobacco Product authorization, progress in international market expansion, and innovations in nicotine biosynthesis control. Regular updates ensure informed tracking of this biotechnology firm's unique position at the intersection of public health and commercial tobacco production.

Bookmark this page for streamlined access to verified corporate announcements and analysis-free reporting on 22nd Century's progress in redefining tobacco consumption through science-driven solutions.

Rhea-AI Summary

22nd Century Group, Inc. (XXII) announces the expansion of its VLN® reduced nicotine cigarettes into Utah, Arizona, and New Mexico, following the Colorado launch. The company aims to tap into a massive market, emphasizing that every 1% of the U.S. market correlates to approximately $800 million in retail sales. With favorable MRTP excise tax programs in these states, 22nd Century plans to utilize established partners for efficient distribution. VLN® products are designed to help adult smokers reduce their nicotine intake, with previous pilot programs demonstrating success in consumer recommendations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
-
Rhea-AI Summary

22nd Century Group, Inc. (Nasdaq: XXII) has announced that CEO James A. Mish will present at the LD Micro Main Event Investor Conference in Los Angeles on October 26, 2022, at 11:00 a.m. PT. The event is highly anticipated, with limited space for investor meetings due to demand. Institutional investors can arrange meetings through LD Micro representatives or by contacting the investor relations team. A live and archived webcast of the presentation will be available on the company's Investor Relations website shortly after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced that CEO James A. Mish will present at the 7th Annual Dawson James Small Cap Growth Conference on October 12, 2022, in Jupiter, Florida. The company's presentation is scheduled for 10:30 AM ET. Interested institutional investors can request meetings with management through their representatives or by contacting the investor relations team at investorrelations@xxiicentury.com. 22nd Century Group specializes in agricultural biotechnology, focusing on reduced nicotine tobacco, hemp, and cannabis technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.12%
Tags
conferences
Rhea-AI Summary

22nd Century Group has launched VLN® cigarettes in Colorado, the first FDA-approved Modified Risk Tobacco Product, featuring 95% less nicotine than regular cigarettes. This initiative aims to help smokers reduce consumption and quit smoking. VLN® King and Menthol King are now available at Smoker Friendly locations and will soon be in Circle K stores. Clinical trials show switching to VLN® can reduce cigarettes per day by 50% after 20 weeks. The rollout aligns with public health goals and aims to reduce smoking-related deaths, particularly among Colorado's adult smokers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
-
Rhea-AI Summary

22nd Century Group (XXII) has partnered with Creager Mercantile to enhance the distribution of its VLN® reduced nicotine content cigarettes across Colorado. This collaboration aims to boost availability in over 1,000 retail locations, including specialty shops and gas stations. VLN® cigarettes contain about 95% less nicotine than standard cigarettes, promoting a non-addictive alternative. The effort follows a successful pilot program in Chicago, establishing a channel for wider retail presence. This partnership represents a strategic move to tap into Colorado's retail market, with plans for further expansion nationwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced a partnership with Eagle Rock Distributing to launch its VLN® reduced nicotine cigarettes across Colorado starting September 2022. This collaboration aims to distribute VLN® to thousands of locations, including regional and national chains and independent retailers. VLN® cigarettes contain approximately 95% less nicotine, addressing health concerns associated with conventional smoking. The partnership follows a successful pilot program in Chicago, which showed high customer recommendation rates for VLN®. This initiative is aligned with the FDA's proposed nicotine cap to reduce smoking.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.56%
Tags
partnership
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) aligns with the FDA and the Biden Administration's initiative to reduce nicotine content in cigarettes, aiming to help smokers cut down. Their VLN® reduced nicotine content cigarettes are designed to aid smokers in reducing their nicotine intake, with plans for expanded sales in Chicago following successful pilot results. The FDA's proposed actions could significantly impact public health, potentially helping over 5 million people quit smoking. These initiatives address the high addiction rates linked to nicotine and the associated health risks, including cancer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.44%
Tags
none
-
Rhea-AI Summary

22nd Century Group, Inc. (Nasdaq: XXII) announced the appointment of Lucie S. Salhany to its Board of Directors on September 12, 2022. Salhany, a renowned media executive with a history of successful product launches, will enhance the company's focus on tobacco harm reduction and its hemp/cannabis initiatives. Her experience includes being the first woman chair of a major broadcast network, and she will serve on the Corporate Governance and Finance committees. Board Chair Nora B. Sullivan and CEO James A. Mish expressed confidence in her ability to elevate the company's market profile.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.44%
Tags
management
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced significant management changes aimed at accelerating growth in its reduced nicotine content tobacco business. Michael Zercher, President and COO, will depart by September 30, 2022, while John Miller will take over the tobacco-related duties. CEO James A. Mish will also assume the title of Corporate President. The company reported successful pilot results for its VLN® reduced nicotine tobacco product, paving the way for expanded sales and market rollouts across the U.S. This strategic shift is designed to enhance coordination for upcoming product launches.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.15%
Tags
none
Rhea-AI Summary

22nd Century Group, Inc. (XXII) is expanding its VLN® tobacco sales in September, targeting additional stores in Illinois and launching in Colorado through new distribution partnerships. VLN® cigarettes contain 95% less nicotine than traditional cigarettes, promoting a non-addictive smoking option. Partnerships with major retailers like Circle K and Smoker Friendly® will enhance product availability, adding thousands of additional points of sale. The company's strong pilot results in Chicago indicate high demand, aiming to capture a significant share of the $80 billion U.S. tobacco market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.56%
Tags
none

FAQ

What is the current stock price of 22Nd Century (XXII)?

The current stock price of 22Nd Century (XXII) is $1.51 as of October 21, 2025.

What is the market cap of 22Nd Century (XXII)?

The market cap of 22Nd Century (XXII) is approximately 5.8M.
22Nd Century

Nasdaq:XXII

XXII Rankings

XXII Stock Data

5.82M
3.71M
1.91%
0.88%
2.77%
Tobacco
Cigarettes
Link
United States
WILLIAMSVILLE